Curebound is a 501(c)(3) organization, classified under Disease & Disorders (NTEE G123). Contributions are tax-deductible.
9605 Scranton Rd Ste 120, San Diego, CA 92121-1767
Among the 24 scored disease & disorders organizations in San Diego, Curebound holds 7.3 months of operating reserves (peer median 13.8 months), runs a typical yearly deficit of 21.5% (peers: surplus of 0.9%), and has grown spending 33.6% a year (peers: grown spending 3.8% a year).
In fiscal year 2025 it reported $10,968,237 in revenue and $14,851,654 in expenses, with contributions making up 72.7% of revenue.
Curebound's mission is to accelerate cancer research and save lives. We raise and invest strategic funding for innovative adult and pediatric cancer research with one vision: Cures in our lifetime.
Main program · fiscal year 2025
Curebound is a community-powered cancer research accelerator with a unique funding model built on a core belief that the best ideas happen when the right people work together. We unite top scientists, passionate advocates, entrepreneurs and investors to advance cancer research that has the greatest opportunity to improve detection, treatment, and survivorship. All Curebound grants demand scientifi… Read more
Curebound is a community-powered cancer research accelerator with a unique funding model built on a core belief that the best ideas happen when the right people work together. We unite top scientists, passionate advocates, entrepreneurs and investors to advance cancer research that has the greatest opportunity to improve detection, treatment, and survivorship. All Curebound grants demand scientific collaboration across institutions to drive results for patients who need it now. Through rigorous review and transparency, we direct every investment dollar towards meaningful impact. Representative research partner institutions include (but not limited to): Uc San Diego moores cancer center, the salk institute, sanford-burnham prebys medical discovery institute, rady children's hospital, scripps research, and la jolla institute of immunology.headquartered in San Diego, one of the nation's premier hubs for cancer research and life-science innovation, Curebound catalyzes complementary strengths across biology, technology, data science, and clinical networks to accelerate the translation of discovery into clinical impact. Curebound allocates and administers research funding through five grant mechanisms spanning discovery through clinical translation: Discovery, targeted, catalyst, equity, cure prize. Each of these grant types aligns to Curebound's overarching and research roadmap with clearly defined timelines and measurable milestones that are tracked to accelerate progress.
$11,714,338 spent
Where each dollar went · fiscal year 2025
Of every dollar it spent, 79¢ went to programs, 11¢ to management and 10¢ to fundraising.
Programs $11,714,338
Management $1,688,385
Fundraising $1,448,931
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Spending on programs Not scored; America's Best needs 65%+
79%
Meets
Compared with San Diego peers
Measure
This organization
Peer median
Operating reserves
7.3 mo
13.8 mo
Typical margin
−21.5%
+0.9%
Spending growth
+33.6% / yr
+3.8% / yr
Debt load
23.8%
12.4%
Peers: the 24 San Diego disease & disorders organizations with a score, ranked or below the bar.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$10,968,237Fiscal year 2025
Expenses$14,851,654Fiscal year 2025
Total assets$11,857,815Fiscal year 2025
Total liabilities$2,822,688Fiscal year 2025
Fiscal year ending December2025
Revenue$10,968,237
Expenses$14,851,654
Net income−$3,883,417
Net assets$9,035,127
Notable sources of revenue
Percent of total revenue
Contributions
$7,968,991
72.7%
Program services
$0
0.0%
Investment income
$343,112
3.1%
Other (net)
$2,656,134
24.2%
Assets / debt
Total assets
$11,857,815
Total liabilities
$2,822,688
Net assets
$9,035,127
Compensation
Not in our extract for this year.
Fiscal year ending December2024
Revenue$5,488,901
Expenses$10,744,443
Net income−$5,255,542
Net assets$12,918,544
Notable sources of revenue
Percent of total revenue
Contributions
$5,672,165
103.3%
Program services
$0
0.0%
Investment income
$522,299
9.5%
Other (net)
−$705,563
−12.9%
Assets / debt
Total assets
$16,440,883
Total liabilities
$3,522,339
Net assets
$12,918,544
Compensation
Not in our extract for this year.
Fiscal year ending December2023
Revenue$10,395,528
Expenses$12,500,342
Net income−$2,104,814
Net assets$18,179,207
Notable sources of revenue
Percent of total revenue
Contributions
$7,931,168
76.3%
Program services
$0
0.0%
Investment income
$246,733
2.4%
Other (net)
$2,217,627
21.3%
Assets / debt
Total assets
$24,388,123
Total liabilities
$6,208,916
Net assets
$18,179,207
Compensation
Not in our extract for this year.
Fiscal year ending December2022
Revenue$19,804,413
Expenses$6,229,069
Net income$13,575,344
Net assets$20,284,021
Notable sources of revenue
Percent of total revenue
Contributions
$18,221,209
92.0%
Program services
$2,931,116
14.8%
Investment income
$48
0.0%
Other (net)
−$1,347,960
−6.8%
Assets / debt
Total assets
$23,579,083
Total liabilities
$3,295,062
Net assets
$20,284,021
Compensation
Officers and key employees
$523,693
Share of expenses
8.4%
Fiscal year ending December2021
Revenue$8,784,431
Expenses$2,833,605
Net income$5,950,826
Net assets$6,707,315
Notable sources of revenue
Percent of total revenue
Contributions
$8,750,114
99.6%
Program services
$76,935
0.9%
Investment income
$13
0.0%
Other (net)
−$42,631
−0.5%
Assets / debt
Total assets
$7,606,274
Total liabilities
$898,959
Net assets
$6,707,315
Compensation
Not in our extract for this year.
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?